BridgeMD
New treatment option for HIV
Official title Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
ClinicalTrials.gov ID: NCT06444360
What this study is testing
- What it's testing
- The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 24. Healthy volunteers may be eligible.
You may be able to join if
- Age 16-24 years, inclusive, at enrollment
- Male or female
- Self-reports condomless anal or vaginal sex while using stimulants (5 hour prior to, or during sex) within the last 4 months; stimulants is defined...
- Willing and able to provide written informed consent for study participation
- Access to a computer/smartphone/tablet that can use video chat (e.g., Zoom or Google Meet)
You likely can't join if
- Unable to provide informed consent due to severe mental or physical illness
- Concurrent enrollment in another HIV prevention or treatment study (enrollment in a substance treatment program is acceptable)
- assigned by chance to IMPACT arm prior to March 2025 study stop
- Non-English-speaking
- Is currently incarcerated or pending incarceration
- Is currently pregnant or planning to become pregnant
See the full eligibility criteria
- Age 16-24 years, inclusive, at enrollment
- Male or female
- Self-reports condomless anal or vaginal sex while using stimulants (5 hour prior to, or during sex) within the last 4 months; stimulants is defined as crystal methamphetamine, cocaine, and MDMA (e.g., ecstasy, molly)
- Willing and able to provide written informed consent for study participation
- Access to a computer/smartphone/tablet that can use video chat (e.g., Zoom or Google Meet)
- Provide a mailing address where they can receive a package
- Access to stable internet that they can use for more than 2 hours at a time
- Have a private place (where no one else can see or hear) where they can complete visits online
- Reside within the continental U.S.
- Unable to provide informed consent due to severe mental or physical illness
- Concurrent enrollment in another HIV prevention or treatment study (enrollment in a substance treatment program is acceptable)
- assigned by chance to IMPACT arm prior to March 2025 study stop
- Non-English-speaking
- Is currently incarcerated or pending incarceration
- Is currently pregnant or planning to become pregnant
- Any other medical condition, medical/behavioral intervention, or other condition that, in the opinion of the Project Lead or designee, could interfere with the safety of participants or staff, adherence to study...
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
- Providence, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 24 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States; Providence, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.